The Future of the Cath Lab: Managing Complexity for Improved Safety and Outcomes in CTO, TAVI, and Carotid Intervention

On-Demand Webcast

This webcast is based on live proceedings from the satellite symposium that was held in conjunction with Transcatheter Cardiovascular Therapeutics (TCT) 2011

Chair

Roxana Mehran, MD, FACC
Professor of Medicine
Director of Interventional Cardiovascular Research and Clinical Trials
Mount Sinai School of Medicine
Chief Scientific Officer
Cardiovascular Research Foundation
New York, New York

Presenters

John R. Laird, MD
Professor of Medicine
Medical Director of the Vascular Center
UC Davis Medical Center
Sacramento, California

Jeffrey W. Moses, MD
Professor of Medicine
Columbia University Medical Center
New York, New York

George D. Dangas, MD, PhD
Professor of Medicine
Mount Sinai School of Medicine
Director of Cardiovascular Innovation
Zena and Michael A. Weiner Cardiovascular Institute
Mount Sinai Medical Center
New York, New York

Learning Objectives

After completing this activity, participants should be able to:

Summarize and apply recent clinical evidence regarding the reduction of risk associated with contrast induced nephropathy
Discuss strategies used to minimize risk of adverse events in complex cases of transcatheter aortic valve implantation, chronic total occlusion, and carotid artery stenting

Intended Learners

This activity is designed for clinical, interventional, and general cardiologists, and nurses, radiologists, and technologists.

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 20-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release date: December 8, 2011
Expiration date: December 8, 2012
Estimated time to complete: 1 hour

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.0 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.

AHRA Accreditation

Approved for 1 ARRT Category A CE Credit by AHRA.

Independent Clinical Reviewer: Arnold Seto, MD, MPA, Assistant Clinical Professor, University of California Medical Center – Irvine, Irvine, California, Director of Interventional Cardiology Research, Long Beach VA Medical Center, Long Beach, California

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California

Planning Committee

The planning committee comprises Roxana Mehran, MD, FACC, John R. Laird, MD, Jeffrey W. Moses, MD, George D. Dangas, MD, PhD, Arnold Seto, MD, MPA, and Susie Seaman, NP; and Kristin Ciszeski, Lauren DeFillippo, Edward Jackson, MD, Rich Keenan, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Mehran: Grant/research support—Bristol-Myers Squibb, sanofi-aventis U.S., The Medicines Company (spouse); Consultant—AstraZeneca; Scientific advisor—Abbott Laboratories, Ortho-McNeil Pharmaceutical, Inc, Regado Biosciences
Dr. Laird: Grant/research support—Atrium Medical; Consultant—Abbot Vascular, Boston Scientific Corp, Cordis Corp, ev3, Inc, Medtronic, Inc, Spectranetics, C. R. Bard, Inc; Scientific advisor—Lutonix, Angioslide, Inc, AngioScore, Inc; Stock shareholder—AccessClosure, Inc; Board Member—VIVA Physicians
Dr. Moses: Consultant—Boston Scientific Corp, Abbott Laboratories
Dr. Dangas: Grant/research support—Bristol-Myers Squibb (spouse), sanofi-aventis U.S. (spouse), The Medicines Company; Consultant—AstraZeneca (spouse); Scientific advisor—Abbott Laboratories (spouse), Ortho-McNeil Pharmaceutical, Inc (spouse), Regado Biosciences (spouse)
Dr. Seto: Stock shareholder—Abbott Laboratories
Ms. Seaman: Scientific advisor—Molnlycke; Promotional Speakers' Bureau—Molnlycke

Ms. Ciszeski, Ms. DeFillippo, Dr. Jackson, Mr. Keenan, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: investigational guided CTO crossing catheter and investigational aortic valve devices (Medtronic CoreValve™, Direct Flow, Sadra, AorTx, Jena Valve, Heart Leaflet Technologies, Advanced Bio Prosthetic Surfaces PercValve, EndoTech, Ventor Embracer, Claret Dual Filter System, Embrella Embolic Deflector).

This continuing medical education activity includes device brand names for participant clarity purposes only, due to the presence of different branded versions of the same device. No product promotion or recommendation should be inferred.

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from ACIST Medical Systems.